시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 심장 AI 모니터링 및 진단 시장 보고서(2025년)
Cardiac AI Monitoring And Diagnostics Global Market Report 2025
상품코드 : 1682022
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,371,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,209,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,048,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

심장 AI 모니터링 및 진단 시장 규모는 향후 수년간 비약적인 성장이 전망됩니다. 2029년에는 CAGR 26.6%로 55억 4,000만 달러로 성장합니다. 예측 기간의 성장은 웨어러블 및 IoT 기기 확대, 원격의료 및 원격 모니터링 채택 확대, 빅데이터 분석과 예측 모델링의 통합, 환자 중심 치료 및 원격 환자 참여에 대한 강조, 헬스케어 인프라 개발 등에 기인합니다. 예측 기간의 주요 동향으로는 웨어러블 기기와 AI의 통합, 개인화된 위험 평가 및 치료 계획, 심혈관 사건 예측 분석, 멀티모달 데이터 소스의 통합, 상호운용성 및 데이터 통합 표준 등이 있습니다.

심혈관 질환(CVDs)의 유병률 증가는 심장 AI 모니터링 및 진단 시장의 성장을 가속할 것으로 예상되며, CVD는 뇌혈관 질환, 관상동맥 질환, 류마티스성 심장질환 등 심장과 혈관에 영향을 미치는 다양한 질환을 포함합니다. 심장 AI 모니터링 및 진단은 심혈관 질환의 조기 진단, 위험 평가, 맞춤 치료를 촉진하고 환자의 결과를 개선할 수 있습니다. 예를 들어 2024년 9월 영국에 기반을 둔 심혈관 연구 자선단체인 British Heart Foundation의 데이터에 따르면 영국에서 약 760만 명이 심장 및 순환기 질환을 앓고 있으며, 그 중 남성은 약 400만 명, 여성은 약 360만 명이 앓고 있다고 합니다. 이들 질환은 영국 전체 사망자의 약 27%를 차지하며, 연간 17만 명 이상, 하루 약 480명, 3분마다 1명씩 사망하고 있습니다. 결과적으로 심혈관 질환 발생률 증가는 심장 AI 모니터링 및 진단 시장의 성장에 박차를 가하고 있습니다.

심장 AI 모니터링 및 진단 시장에서 활동하는 주요 기업은 인공지능 기반 이식형 심장 모니터와 같은 기술 주도형 의료기기 개발에 주력하며 시장에서의 입지를 확고히 하고 있습니다. 인공지능 기반 이식형 심장 모니터는 심혈관 건강관리의 획기적인 혁신으로, 심장 기능을 지속적으로 정확하게 모니터링할 수 있습니다. 예를 들어 2023년 5월 독일에 본사를 둔 유명한 심혈관 바이오메디컬 연구 및 기술 기업인 바이오트로닉(Biotronik)은 BIOMONITOR IV 이식형 심장 모니터(ICM)의 FDA 승인을 발표했습니다. 인공지능을 활용한 바이오트로닉의 최첨단 SmartECG 알고리즘을 탑재한 BIOMONITOR IV ICM은 심장 모니터링의 정확성에 대한 새로운 기준을 제시합니다. 첨단 알고리즘을 활용하는 SmartECG 기술은 실제 심장 에피소드의 높은 감지율을 유지하면서 오인 가능성을 크게 줄입니다. 이러한 향상된 감지 정확도를 통해 의료 전문가는 신속하고 정확한 진단을 내릴 수 있으며, 환자 치료와 결과를 최적화할 수 있습니다. 또한 BIOMONITOR IV ICM은 조기 심실수축(PVC) 및 조기 심방수축(PAC)과 같은 다른 유형의 심박동 유형을 구분하여 진단 능력과 임상적 유용성을 더욱 향상시킵니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Cardiac AI monitoring and diagnostics involve the application of artificial intelligence (AI) technologies in the field of cardiology to monitor and diagnose various cardiovascular conditions. This utilizes advanced algorithms and machine learning techniques to analyze data from cardiac monitoring devices, such as electrocardiograms (ECGs).

The main categories of cardiac AI monitoring and diagnostics are cardiac diagnostics and cardiac monitoring. Cardiac diagnostics encompass methods and procedures used to identify heart conditions associated with unhealthy or pathologic heart function. The products in this category include software and hardware used in applications such as ischemic heart diseases or coronary artery disease (CAD), cardiac arrhythmias, ischemic stroke, and others. End users of these cardiac AI solutions include hospitals, diagnostic centers, and various healthcare facilities.

The cardiac AI monitoring and diagnostics research report is one of a series of new reports from The Business Research Company that provides cardiac AI monitoring and diagnostics market statistics, including the cardiac AI monitoring and diagnostics industry's global market size, regional shares, competitors with an cardiac AI monitoring and diagnostics market share, detailed cardiac AI monitoring and diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac AI monitoring and diagnostics industry. This cardiac AI monitoring and diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cardiac ai monitoring and diagnostics market size has grown exponentially in recent years. It will grow from $1.71 billion in 2024 to $2.16 billion in 2025 at a compound annual growth rate (CAGR) of 26.4%. The growth in the historic period can be attributed to aging population demographics, rise in remote patient monitoring, increased healthcare expenditure, clinical research and validation studies, focus on preventive healthcare.

The cardiac ai monitoring and diagnostics market size is expected to see exponential growth in the next few years. It will grow to $5.54 billion in 2029 at a compound annual growth rate (CAGR) of 26.6%. The growth in the forecast period can be attributed to expansion of wearable and IoT devices, increasing adoption of telemedicine and remote monitoring, integration of big data analytics and predictive modeling, focus on patient-centered care and remote patient engagement, healthcare infrastructure development. Major trends in the forecast period include integration of AI with wearable devices, personalized risk assessment and treatment planning, predictive analytics for cardiovascular events, integration of multimodal data sources, interoperability and data integration standards.

The rising prevalence of cardiovascular diseases (CVDs) is expected to drive growth in the cardiac AI monitoring and diagnostics market. CVDs encompass a range of conditions affecting the heart and blood vessels, including cerebrovascular disease, coronary heart disease, and rheumatic heart disease. Cardiac AI monitoring and diagnostics facilitate early diagnosis, risk assessment, and personalized treatment for cardiovascular conditions, improving patient outcomes. For example, in September 2024, data from the British Heart Foundation, a UK-based cardiovascular research charity, indicated that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with around 4 million men and 3.6 million women affected. These diseases account for about 27% of all deaths in the UK, resulting in over 170,000 deaths annually, or about 480 deaths per day, equivalent to one death every three minutes. Consequently, the increasing incidence of cardiovascular diseases is fueling growth in the cardiac AI monitoring and diagnostics market.

Leading companies operating in the cardiac AI monitoring and diagnostics market are directing their efforts towards the development of technology-driven medical devices, such as artificial intelligence-based implantable cardiac monitors, to solidify their position in the market. Artificial intelligence-based implantable cardiac monitors represent a groundbreaking innovation in cardiovascular healthcare, offering continuous and accurate monitoring of cardiac function. For example, in May 2023, Biotronik, a renowned cardiovascular biomedical research and technology company based in Germany, announced the FDA approval of its BIOMONITOR IV implantable cardiac monitor (ICM). Equipped with BIOTRONIK's cutting-edge SmartECG algorithm powered by artificial intelligence, the BIOMONITOR IV ICM sets a new standard in cardiac monitoring accuracy. By leveraging advanced algorithms, the SmartECG technology significantly reduces false identifications while maintaining a high detection rate for genuine cardiac episodes. This enhancement in detection accuracy empowers healthcare professionals to make prompt and precise diagnoses, thus optimizing patient care and outcomes. Furthermore, the BIOMONITOR IV ICM distinguishes between different types of cardiac contractions, such as premature ventricular contractions (PVCs) and premature atrial contractions (PACs), further enhancing its diagnostic capabilities and clinical utility.

In January 2022, Koninklijke Philips N.V., a healthcare technology company headquartered in the Netherlands, completed the acquisition of Cardiologs Technologies SAS, a medical technology company based in France, for an undisclosed sum. This strategic move positions Cardiologs to enhance Philips' cardiac monitoring and diagnostics portfolio through the integration of innovative software solutions, electrocardiogram (ECG) analysis, and reporting services. Cardiologs Technologies SAS specializes in optimizing cardiac diagnostics through the utilization of artificial intelligence (AI) and cloud technologies, aligning with Philips' commitment to advancing healthcare through cutting-edge innovations.

Major companies operating in the cardiac ai monitoring and diagnostics market report are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, ZOLL Medical Corporation, Canon Medical Systems Corporation, Biotronik SE & Co. KG, iRhythm Technologies Inc., Tempus Labs Inc., Viz.ai Inc., HeartFlow Inc., Aidoc, Eko Devices Inc., CardioFocus Inc., Circle Cardiovascular Imaging Inc., Ultromics Limited., Cathworks, Medicalgorithmics S.A., Nanox.AI Ltd, Cardiac Insight Inc., CardioSecur GmbH, Cardionomic Inc., HeartSciences, CardioComm Solutions Inc., CardioDiagnostics Inc.

North America was the largest region in the cardiac AI monitoring and diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac ai monitoring and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac ai monitoring and diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiac AI monitoring and diagnostics market consists of revenues earned by entities by providing services such as ST-segment monitoring, arrhythmia detection, heart rate variability analysis, risk stratification, and echocardiogram interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac AI monitoring and diagnostics market also includes sales of echocardiography devices, cardiac MRI and CT analysis, electrocardiogram (ECG) analysis tools, and wearable devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac AI Monitoring And Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac ai monitoring and diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cardiac ai monitoring and diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac ai monitoring and diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Cardiac AI Monitoring And Diagnostics Market Characteristics

3. Cardiac AI Monitoring And Diagnostics Market Trends And Strategies

4. Cardiac AI Monitoring And Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cardiac AI Monitoring And Diagnostics Growth Analysis And Strategic Analysis Framework

6. Cardiac AI Monitoring And Diagnostics Market Segmentation

7. Cardiac AI Monitoring And Diagnostics Market Regional And Country Analysis

8. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market

9. China Cardiac AI Monitoring And Diagnostics Market

10. India Cardiac AI Monitoring And Diagnostics Market

11. Japan Cardiac AI Monitoring And Diagnostics Market

12. Australia Cardiac AI Monitoring And Diagnostics Market

13. Indonesia Cardiac AI Monitoring And Diagnostics Market

14. South Korea Cardiac AI Monitoring And Diagnostics Market

15. Western Europe Cardiac AI Monitoring And Diagnostics Market

16. UK Cardiac AI Monitoring And Diagnostics Market

17. Germany Cardiac AI Monitoring And Diagnostics Market

18. France Cardiac AI Monitoring And Diagnostics Market

19. Italy Cardiac AI Monitoring And Diagnostics Market

20. Spain Cardiac AI Monitoring And Diagnostics Market

21. Eastern Europe Cardiac AI Monitoring And Diagnostics Market

22. Russia Cardiac AI Monitoring And Diagnostics Market

23. North America Cardiac AI Monitoring And Diagnostics Market

24. USA Cardiac AI Monitoring And Diagnostics Market

25. Canada Cardiac AI Monitoring And Diagnostics Market

26. South America Cardiac AI Monitoring And Diagnostics Market

27. Brazil Cardiac AI Monitoring And Diagnostics Market

28. Middle East Cardiac AI Monitoring And Diagnostics Market

29. Africa Cardiac AI Monitoring And Diagnostics Market

30. Cardiac AI Monitoring And Diagnostics Market Competitive Landscape And Company Profiles

31. Cardiac AI Monitoring And Diagnostics Market Other Major And Innovative Companies

32. Global Cardiac AI Monitoring And Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac AI Monitoring And Diagnostics Market

34. Recent Developments In The Cardiac AI Monitoring And Diagnostics Market

35. Cardiac AI Monitoring And Diagnostics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기